Valuation Shanghai Shyndec Pharmaceutical Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2024-12-06			5-day change	1st Jan Change
12.28 ^CNY	+1.82%		+0.82%	+25.43%

Dec. 06	Shyndec Pharma Unit's Codeine Phosphate Included in China's Listing of Chemical Raw Materials	MT
Dec. 03	Shanghai Shyndec Pharmaceutical Gets Drug Registration for Eye Drops	MT

Data adjusted to current consolidation scope

Fiscal Period: december	2022	2023	2024	2025	2026
Capitalization ¹	9,346	13,130	16,470	-	-
Change	-	40.5%	25.43%	-	-
Enterprise Value (EV)	9,346	13,130	16,470	16,470	16,470
Change	-	40.5%	25.43%	0%	0%
P/E ratio	14.9x	18x	14.1x	11.9x	10.5x
PBR	-	1.06x	1.23x	1.17x	1.09x
PEG	-	-1.6x	0.2x	0.6x	0.8x
Capitalization / Revenue	-	1.09x	1.37x	1.28x	1.2x
EV / Revenue	-	0x	1.37x	1.28x	1.2x
EV / EBITDA	-	-	6.78x	5.96x	5.3x
EV / EBIT	-	-	8.97x	7.63x	6.61x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	0.1	0.1	1.085	1.205
Rate of return	-	1.02%	0.81%	8.84%	9.81%
EPS ²	0.6101	0.5433	0.87	1.03	1.165
Distribution rate	-	18.4%	11.5%	105%	103%
Net sales ¹	-	12,070	12,024	12,876	13,704
EBITDA ¹	-	-	2,428	2,763	3,110
EBIT ¹	-	-	1,836	2,159	2,493
Net income ¹	626.6	691.9	1,173	1,376	1,556
Net Debt	-	-	-	-	-
Reference price ²	9.10	9.79	12.28	12.28	12.28
Nbr of stocks (in thousands)	1,026,983	1,341,173	1,341,173	-	-
Announcement Date	1/13/23	3/29/24	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	14.11x	-	-	+0.81%	2.27B
MERCK KGAA	20.78x	3.21x	11.24x	+1.67%	64.21B
KYOWA KIRIN CO. LTD.	18.84x	1.89x	8.18x	+2.35%	8.34B
HALOZYME THERAPEUTICS, INC.	13.73x	7.36x	13.5x	-	6.16B
YUHAN CORPORATION	66.97x	4.05x	52.15x	+0.37%	6.05B
SK BIOPHARMACEUTICALS CO., LTD.	117.5x	14.71x	79.62x	-.--%	5.61B
BETTA PHARMACEUTICALS CO., LTD.	45.65x	8.38x	24.45x	+0.48%	3.31B
SUPERNUS PHARMACEUTICALS, INC.	39.13x	-	-	-	2.05B
Average	42.09x	6.60x	31.52x	+0.95%	12.25B
Weighted average by Cap.	29.63x	4.29x	18.32x	+1.48%